These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22825336)

  • 41. The checkpoint 1 kinase inhibitor LY2603618 induces cell cycle arrest, DNA damage response and autophagy in cancer cells.
    Wang FZ; Fei HR; Cui YJ; Sun YK; Li ZM; Wang XY; Yang XY; Zhang JG; Sun BL
    Apoptosis; 2014 Sep; 19(9):1389-98. PubMed ID: 24928205
    [TBL] [Abstract][Full Text] [Related]  

  • 42. UNC45A localizes to centrosomes and regulates cancer cell proliferation through ChK1 activation.
    Jilani Y; Lu S; Lei H; Karnitz LM; Chadli A
    Cancer Lett; 2015 Feb; 357(1):114-120. PubMed ID: 25444911
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effects of RNA interference on CHK1 and CHK2 expression and G2/M arrest in esophageal carcinoma cell line TE13 after irradiation].
    Zhu SC; Wang YX; Li R; Han C; Qiu R; Shen WB
    Ai Zheng; 2007 Feb; 26(2):127-31. PubMed ID: 17298739
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Requirement of MTA1 in ATR-mediated DNA damage checkpoint function.
    Li DQ; Ohshiro K; Khan MN; Kumar R
    J Biol Chem; 2010 Jun; 285(26):19802-12. PubMed ID: 20427275
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Destruction of Claspin by SCFbetaTrCP restrains Chk1 activation and facilitates recovery from genotoxic stress.
    Mailand N; Bekker-Jensen S; Bartek J; Lukas J
    Mol Cell; 2006 Aug; 23(3):307-18. PubMed ID: 16885021
    [TBL] [Abstract][Full Text] [Related]  

  • 46. RRM1 maintains centrosomal integrity via CHK1 and CDK1 signaling during replication stress.
    Kim SH; Park ER; Joo HY; Shen YN; Hong SH; Kim CH; Singh R; Lee KH; Shin HJ
    Cancer Lett; 2014 May; 346(2):249-56. PubMed ID: 24434653
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phosphorylation activates Chk1 and is required for checkpoint-mediated cell cycle arrest.
    Capasso H; Palermo C; Wan S; Rao H; John UP; O'Connell MJ; Walworth NC
    J Cell Sci; 2002 Dec; 115(Pt 23):4555-64. PubMed ID: 12415000
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chk1, but not Chk2, is responsible for G2/M phase arrest induced by diallyl disulfide in human gastric cancer BGC823 cells.
    Bo S; Hui H; Li W; Hui L; Hong X; Lin D; Dai WX; Wu YH; Ai XH; Hao J; Qi S
    Food Chem Toxicol; 2014 Jun; 68():61-70. PubMed ID: 24650757
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MDC1 is a mediator of the mammalian DNA damage checkpoint.
    Stewart GS; Wang B; Bignell CR; Taylor AM; Elledge SJ
    Nature; 2003 Feb; 421(6926):961-6. PubMed ID: 12607005
    [TBL] [Abstract][Full Text] [Related]  

  • 50. p53-dependent G(1) arrest in 1st or 2nd cell cycle may protect human cancer cells from cell death after treatment with ionizing radiation and Chk1 inhibitors.
    Petersen L; Hasvold G; Lukas J; Bartek J; Syljuåsen RG
    Cell Prolif; 2010 Aug; 43(4):365-71. PubMed ID: 20590661
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The efficacy of CHK1 inhibitors is not altered by hypoxia, but is enhanced after reoxygenation.
    Hasvold G; Nähse-Kumpf V; Tkacz-Stachowska K; Rofstad EK; Syljuåsen RG
    Mol Cancer Ther; 2013 May; 12(5):705-16. PubMed ID: 23635654
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Knockdown of Chk1, Wee1 and Myt1 by RNA interference abrogates G2 checkpoint and induces apoptosis.
    Wang Y; Decker SJ; Sebolt-Leopold J
    Cancer Biol Ther; 2004 Mar; 3(3):305-13. PubMed ID: 14726685
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chk1 C-terminal regulatory phosphorylation mediates checkpoint activation by de-repression of Chk1 catalytic activity.
    Walker M; Black EJ; Oehler V; Gillespie DA; Scott MT
    Oncogene; 2009 Jun; 28(24):2314-23. PubMed ID: 19421147
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enhanced H2AX phosphorylation, DNA replication fork arrest, and cell death in the absence of Chk1.
    Gagou ME; Zuazua-Villar P; Meuth M
    Mol Biol Cell; 2010 Mar; 21(5):739-52. PubMed ID: 20053681
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chk1 mediates S and G2 arrests through Cdc25A degradation in response to DNA-damaging agents.
    Xiao Z; Chen Z; Gunasekera AH; Sowin TJ; Rosenberg SH; Fesik S; Zhang H
    J Biol Chem; 2003 Jun; 278(24):21767-73. PubMed ID: 12676925
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The DNA damage effector Chk1 kinase regulates Cdc14B nucleolar shuttling during cell cycle progression.
    Peddibhotla S; Wei Z; Papineni R; Lam MH; Rosen JM; Zhang P
    Cell Cycle; 2011 Feb; 10(4):671-9. PubMed ID: 21301228
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rad17 phosphorylation is required for claspin recruitment and Chk1 activation in response to replication stress.
    Wang X; Zou L; Lu T; Bao S; Hurov KE; Hittelman WN; Elledge SJ; Li L
    Mol Cell; 2006 Aug; 23(3):331-41. PubMed ID: 16885023
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cyclin B1 is an efficacy-predicting biomarker for Chk1 inhibitors.
    Xiao Z; Xue J; Gu WZ; Bui M; Li G; Tao ZF; Lin NH; Sowin TJ; Zhang H
    Biomarkers; 2008 Sep; 13(6):579-96. PubMed ID: 18671143
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An essential role for MCL-1 in ATR-mediated CHK1 phosphorylation.
    Jamil S; Mojtabavi S; Hojabrpour P; Cheah S; Duronio V
    Mol Biol Cell; 2008 Aug; 19(8):3212-20. PubMed ID: 18495871
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sensitization to gamma-irradiation-induced cell cycle arrest and apoptosis by the histone deacetylase inhibitor trichostatin A in non-small cell lung cancer (NSCLC) cells.
    Zhang F; Zhang T; Teng ZH; Zhang R; Wang JB; Mei QB
    Cancer Biol Ther; 2009 May; 8(9):823-31. PubMed ID: 19270532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.